Literature DB >> 3046483

Isolation and characterization of a penicillinase from Pseudomonas cepacia 249.

A Prince1, M S Wood, G S Cacalano, N X Chin.   

Abstract

Pseudomonas cepacia has an inducible beta-lactamase which is responsible for its novel ability to catabolize beta-lactam compounds. The gene encoding this enzyme, penA, was cloned from a genomic library of P. cepacia 249 on the broad-host-range cosmid pLAFR. This separated the penA gene from the gene encoding a second beta-lactamase in P. cepacia 249. Expression of penA was inducible in an Escherichia coli host strain by low levels of penicillin. The 33,500-molecular-weight enzyme had penicillinase activity not inhibited by clavulanic acid or sulbactam and was highly active against piperacillin and azlocillin. In comparison with other inducible beta-lactamases produced by gram-negative organisms, the penA enzyme had many properties which were similar to those of the penicillinase produced by Alcaligenes faecalis. It was unlike the ampC-type cephalosporinase produced by Pseudomonas aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3046483      PMCID: PMC172292          DOI: 10.1128/AAC.32.6.838

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid.

Authors:  A C Chang; S N Cohen
Journal:  J Bacteriol       Date:  1978-06       Impact factor: 3.490

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Utilization of two distinct modes of replication by a hybrid plasmid constructed in vitro from separate replicons.

Authors:  K Timmis; F Cabello; S N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

Review 4.  Methodology for the study of beta-lactamases.

Authors:  K Bush; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

Review 5.  The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics.

Authors:  R B Sykes; M Matthew
Journal:  J Antimicrob Chemother       Date:  1976-06       Impact factor: 5.790

6.  An efficient and reproducible procedure for the formation of spheroplasts from variously grown Escherichia coli.

Authors:  B Witholt; M Boekhout; M Brock; J Kingma; H V Heerikhuizen; L D Leij
Journal:  Anal Biochem       Date:  1976-07       Impact factor: 3.365

7.  Induction kinetics of beta-lactamase biosynthesis in Pseudomonas aeruginosa.

Authors:  K Nordström; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

8.  Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia.

Authors:  T R Parr; R A Moore; L V Moore; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

9.  Decreased baseline beta-lactamase production and inducibility associated with increased piperacillin susceptibility of Pseudomonas cepacia isolated from children with cystic fibrosis.

Authors:  C Chiesa; P H Labrozzi; S C Aronoff
Journal:  Pediatr Res       Date:  1986-11       Impact factor: 3.756

10.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

View more
  15 in total

Review 1.  Classification of beta-lactamases: groups 2c, 2d, 2e, 3, and 4.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

2.  Analysis of the penA gene of Pseudomonas cepacia 249.

Authors:  B Joris; M Galleni; J M Frère; R Labia
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

3.  Characterization of the penA and penR genes of Burkholderia cepacia 249 which encode the chromosomal class A penicillinase and its LysR-type transcriptional regulator.

Authors:  S Trépanier; A Prince; A Huletsky
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

Review 4.  Carbapenem-hydrolyzing beta-lactamases.

Authors:  B A Rasmussen; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

Review 5.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

6.  Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex.

Authors:  Laurent Poirel; José-Manuel Rodriguez-Martinez; Patrick Plésiat; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

7.  The Pseudomonas cepacia 249 chromosomal penicillinase is a member of the AmpC family of chromosomal beta-lactamases.

Authors:  R Proenca; W W Niu; G Cacalano; A Prince
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

8.  Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance.

Authors:  J L Burns; C D Wadsworth; J J Barry; C P Goodall
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

9.  Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein.

Authors:  J L Burns; D K Clark
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

10.  Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia).

Authors:  Bindu M Nair; K-John Cheung; Adam Griffith; Jane L Burns
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.